Market Cap

Galectin Therapeutics, Inc. Market Capitalization:

$138.0 Million

USD as of July 1, 2025

business Galectin Therapeutics, Inc. Company Profile

Galectin Therapeutics, Inc. Main Stock Listing

NASDAQ: GALT

Market Capitalization History of Galectin Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of Galectin Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $76.6 M -27.18%
Jan. 1, 2024 $105.1 M 53.85%
Jan. 1, 2023 $68.3 M -40.93%
Jan. 1, 2022 $115.7 M -1.53%
Jan. 1, 2021 $117.5 M -25.48%
Jan. 1, 2020 $157.7 M -45.66%
Jan. 1, 2019 $290.1 M 4.99%
Jan. 1, 2018 $276.4 M 365.66%
Jan. 1, 2017 $59.3 M -29.79%
Jan. 1, 2016 $84.5 M -56.21%
Jan. 1, 2015 $193.0 M -76.51%
Jan. 1, 2014 $821.9 M 433.46%
Jan. 1, 2013 $154.1 M -47.12%
Jan. 1, 2012 $291.3 M -34.68%
Jan. 1, 2011 $446.0 M 342.86%
Jan. 1, 2010 $100.7 M 133.33%
Jan. 1, 2009 $43.2 M -79.31%
Jan. 1, 2008 $208.6 M 100.00%
Jan. 1, 2007 $104.3 M -90.33%
Jan. 1, 2006 $1.08 B 3.81%
Jan. 1, 2005 $1.04 B -29.34%
Jan. 1, 2004 $1.47 B 48.73%
Jan. 1, 2003 $989.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Stocks & Indices

Galectin Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: GALT

Stock: FSX: PHPN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.